Combate, Jelly S.
HRN: 18-00-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2024
METRONIDAZOLE 500MG (TAB)
02/02/2024
02/09/2024
PO
500MG
TID
FDU
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes